Related Experiment Video
Updated: Jan 21, 2026

Antibody Profiling by Luciferase Immunoprecipitation Systems LIPS
Published on: October 7, 2009
Lnc-C/EBPβ Modulates Differentiation of MDSCs Through Downregulating IL4i1 With C/EBPβ LIP and WDR5
Yunhuan Gao1,2,3, Wencong Shang1,2,3, Dan Zhang4
1State Key Laboratory of Medicinal Chemical Biology, Nankai University, Tianjin, China.
Abstract:
Myeloid-derived suppressor cells (MDSCs), which play an important role in tumor and inflammatory diseases, are divided into two subsets CD11b+Ly6ChiLy6G- monocytic MDSC (Mo-MDSC) and CD11b+Ly6Clow/negLy6G+ polymorphonuclear MDSC (PMN-MDSC) with different immunosuppressive function. However, it is poorly understood the mechanism(s) to control differentiation of Mo-MDSCs and PMN-MDSCs. Here, we found that lnc-C/EBPβ may promote PMN-MDSC but impede differentiation of Mo-MDSCs in vitro and in vivo. We demonstrated that lnc-C/EBPβ mediated differentiation of MDSCs was through downregulating multiple transcripts such as IL4il. Lnc-C/EBPβ not only bound to C/EBPβ isoform LIP to inhibit the activation of C/EBPβ but also interacted with WDR5 to interrupt the enrichment of H3K4me3 mark on the promoter region of IL4i1. Data also imply that conserved homo lnc-C/EBPβ has a similar function with mouse lnc-C/EBPβ. Since MDSC subsets exert different suppressive function, lnc-C/EBPβ may be acted as a potential therapeutic target for inflammatory and tumor-associated diseases.
Insights
A novel long non-coding RNA, lnc-C/EBPβ, regulates myeloid-derived suppressor cell (MDSC) differentiation. It promotes polymorphonuclear MDSCs (PMN-MDSCs) while hindering monocytic MDSCs (Mo-MDSCs), offering a potential therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Cancer Research
Background:
- Myeloid-derived suppressor cells (MDSCs) are crucial in tumor and inflammatory diseases.
- MDSCs comprise monocytic (Mo-MDSC) and polymorphonuclear (PMN-MDSC) subsets with distinct immunosuppressive functions.
- Mechanisms controlling MDSC subset differentiation remain largely unknown.
Purpose of the Study:
- To investigate the role of lnc-C/EBPβ in regulating Mo-MDSC and PMN-MDSC differentiation.
- To elucidate the molecular mechanisms by which lnc-C/EBPβ controls MDSC subset development.
Main Methods:
- In vitro and in vivo differentiation assays.
- RNA sequencing and transcriptomic analysis to identify downstream targets.
- Chromatin immunoprecipitation and biochemical assays to determine molecular interactions.
Main Results:
- lnc-C/EBPβ promotes PMN-MDSC differentiation and impedes Mo-MDSC differentiation.
- lnc-C/EBPβ downregulates IL4i1 expression, a key transcript in MDSC differentiation.
- lnc-C/EBPβ interacts with C/EBPβ and WDR5, inhibiting C/EBPβ activation and H3K4me3 enrichment at the IL4i1 promoter.
Conclusions:
- lnc-C/EBPβ is a critical regulator of MDSC subset differentiation.
- The findings reveal a novel mechanism controlling MDSC development.
- lnc-C/EBPβ represents a potential therapeutic target for inflammatory and tumor-associated diseases.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Cellular Differentiation
A zygote is a...
Differential Leveling
Implicit Differentiation
Logarithmic Differentiation
Differential Relays

